TGF?-induced phosphorylation of Par6 promotes migration and invasion in prostate cancer cells.
Ontology highlight
ABSTRACT: The Par complex - comprising partition-defective 6 (Par6), Par3, and atypical protein kinase C (aPKC) - is crucial for cell polarisation, the loss of which contributes to cancer progression. Transforming growth factor ? (TGF?)-induced phosphorylation of Par6 on the conserved serine 345 is implicated in epithelial-to-mesenchymal transition (EMT) in breast cancer. Here we investigated the importance of phosphorylated Par6 in prostate cancer.We generated a p-Par6(345)-specific antibody and verified its specificity in vitro. Endogenous p-Par6(345) was analysed by immunoblotting in normal human prostate RWPE1 and prostate cancer (PC-3U) cells. Subcellular localisation of p-Par6(345) in migrating TGF?-treated PC-3U cells was analysed by confocal imaging. Invasion assays of TGF?-treated PC-3U cells were performed. p-Par6 expression was immunohistochemically analysed in prostate cancer tissues.TGF? induced Par6 phosphorylation on Ser345 and its recruitment to the leading edge of the membrane ruffle in migrating PC-3U cells, where it colocalised with aPKC?. The p-Par6-aPKC? complex is important for cell migration and invasion, as interference with this complex prevented prostate cancer cell invasion. High levels of activated Par6 correlated with aggressive prostate cancer.Increased p-Par6Ser(345) levels in aggressive prostate cancer tissues and cells suggest that it could be a useful novel biomarker for predicting prostate cancer progression.
SUBMITTER: Mu Y
PROVIDER: S-EPMC4385960 | biostudies-literature | 2015 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA